CA MA · Latest: CA Notice complete
Laboratory Corporation of America Holdings will acquire BioReference’s laboratory testing businesses focused on oncology-related clinical testing services across the United States.
Provider merger/affiliation increasing NPSR $10M
| State | Agency | Status | Stage | Source |
|---|---|---|---|---|
| CA | Office of Health Care Affordability (HCAI) | CMIR Waived WAIVED | NOTICE | Agency record |
| MA | Massachusetts Health Policy Commission | No NO_CMIR | NOTICE | Agency record |
No changes observed since the initial load (CA · MA ).
Grouped by DocketTrail's reviewed seed list, entry labcorp-bioreference-oncology-2025.
| State | Title as printed | Source key | Key method |
|---|---|---|---|
| CA | Laboratory Corporation of America Holdings | material-change-transaction-notice-labcorp-1365 | FIRST_DOCUMENT_SLUG |
| MA | BioReference Health, LLC / Laboratory Corporation of America Holdings, Inc. | /sites/default/files/2025-03/20250325_Bioreference-Labcorp_MCN.pdf | FIRST_DOCUMENT_PATH |
| State | Source key | First seen by DocketTrail (UTC) | Last checked (UTC) | Page checked |
|---|---|---|---|---|
| CA | material-change-transaction-notice-labcorp-1365 | hcai.ca.gov | ||
| MA | /sites/default/files/2025-03/20250325_Bioreference-Labcorp_MCN.pdf | masshpc.gov |
| Source | Last captured (UTC) |
|---|---|
| https://hcai.ca.gov/affordability/ohca/assess-market-consolidation/material-change-transaction-notices-mcn-and-cost-and-market-impact-review-cmir/ | 2026-10-06T20:33:54.638Z |
| https://masshpc.gov/moat/mcn-cmir/mcn-transactions | 2026-10-06T20:34:01.460Z |